This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Detection of acute kidney injury (AKI)

Authoring team

Detecting acute kidney injury

  • detect acute kidney injury by using any of the following criteria:

    • a rise in serum creatinine of 26 micromol/litre or greater within 48 hours

    • a 50% or greater rise in serum creatinine known or presumed to have occurred within the past 7 days

    • a fall in urine output to less than 0.5 ml/kg/hour for more than 6 hours in adults and more than 8 hours in children and young people

    • a 25% or greater fall in eGFR in children and young people within the past 7 days

Think Kindeys have stated (2)

Stage 1, 2 or 3. At present, there is no standard or agreed wording and this can be configured locally. However, an example for adults (age >18 years) is included here:

  • Rise in creatinine may indicate Acute Kidney Injury stage x (1, 2 or 3)

    • Please review urgently (adults):

      • 1. AKI stage 1 is a rise of >1.5x baseline level, or of > 26 µmol/L within 48h, or a urine output <0.5mL/kg/h for 6-12h

      • 2. AKI stage 2 is a rise of>2x baseline or a urine output <0.5mL/kg/h for >= 12h

      • 3. AKI stage 3 is a rise of>3x baseline or a rise of >1.5 baseline to >354 µmol/L, a urine output <0.3mL/kg/h for >=24h or anuria for >=12 h

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.